S2 E4: Synthetic biology’s potential to change the world. How the shortfall of semi-commercial fermentation capacity is stunting development of new products w Jason Webber

Update: 2022-12-15

Description

Jason Webber, Principal and Co-Founder at Sustainable Conversion Ventures joins host James Mackey on Scale by Design - Venture Capital Show.

Jason Webber explains how many great innovations will die on the vine with the growing shortfall of semi-commercial fermentation capacity. Not necessarily capacity for the multi-billion dollar markets (food/proteins) so much as those getting squeezed out in the sub-billion dollar markets that could be most disruptive. These are typically too small for strategics to care about but ripe for innovation due to stagnation.

Our host James Mackey, SecureVision CEO

Listen to our full episode list here:
https://www.scalebydesign.io/

Follow us:
https://www.linkedin.com/company/scalebydesign/

Our YouTube channel:
https://www.youtube.com/@securevision1677

#1 Rated Embedded Recruitment Firm on G2!
https://www.g2.com/products/securevision/reviews

Thanks for listening!

Comments

In Channel

S2 E16: The Future of Technology: Exploring the Top Sectors, Trends, and Financing Market w Mark Sherman

2023-03-2223:54

S2 E15: Expert Panel. The current economic environment. Fundraising & How VC's are working alongside and advising PortCos in 2023 w Doug Landis, Scott Barker & Brandon Metcalf.

2023-02-2239:06

S2 E14: The Journey of Starting A Micro VC Focused on Student Startups w Gaurav Mehta.

2023-02-1527:05

S2 E13: Maximizing Employee Engagement During Economic Downturns: Strategies for Valuing and Retaining Talent w Raluca Mackey

2023-02-0831:51

S2 E11: The current state of the tech industry's labor market. Talent acquisition strategies for 2023 w Asad Zaman

2023-01-2553:03

S2 E10: The impact of capital market uncertainty on early-stage funding. VC and climate tech w Eren Uman

2023-01-1842:35

S2 E9: Investing in BIPOC, the crypto crash and market trends, products with no differentiating value props w Michael Benezra & Noah Ente

2023-01-1047:22

S2 E8: How to make the career transition into VC. The vast range of opportunity in ClimateTech w David J. Neff

2023-01-0335:02

S2 E7: The value propositions of an operator-led fund. Tapping into the power of the LP community w Scott Barker, GTMfund Co-founder

2022-12-2841:07

S2 E6: Next-gen commerce and how to uncover investment opportunities that most investors miss w Michael Nogen

2022-12-2241:18

S2 E5: Why pharma startups need to innovate the drug development process. The importance of a patient first approach w Leen Kawas

2022-12-2047:25

S2 E4: Synthetic biology’s potential to change the world. How the shortfall of semi-commercial fermentation capacity is stunting development of new products w Jason Webber

2022-12-1554:10

S2 E3: A new way to think about co-founding and bringing scientific products to market. How BioTech will change the world w Vikram Chaudhery and Paul Conley

2022-12-1344:33

S2 E1:The convergence of Consumer Packaged Goods and Biotech. Capital efficiency and unit economics.

2022-12-0537:45

EP 16: Capacity planning, conversion rates & when it makes sense to hire externally w Jen Spencer

2022-11-1740:11

EP 15: Being intentional with your ideal customer profile w/ Patrick Hudgins

2022-10-2846:03

EP 14: Dragons vs Unicorns and the Downside of High Valuations w/ Ross Wolfe, Founding Partner & Managing Director of Diab Venture Partners

2022-10-1138:20

EP 13: Ushering in the next evolution of personalized customer engagement w/Lio Slama, CEO at AskNeo

2022-09-3042:31

EP 12: Scaling ERGs that generate business outcomes w/Anisha Nandi, CEO at Verbate.io

2022-09-2337:19

EP 11: Defining the new category of revenue observability w/Neetha Ratakonda

2022-09-2041:44

00:00

S2 E4: Synthetic biology’s potential to change the world. How the shortfall of semi-commercial fermentation capacity is stunting development of new products w Jason Webber

#box-pro-ellipsis-176168617553478{-webkit-line-clamp:2;}S2 E4: Synthetic biology’s potential to change the world. How the shortfall of semi-commercial fermentation capacity is stunting development of new products w Jason Webber

S2 E4: Synthetic biology’s potential to change the world. How the shortfall of semi-commercial fermentation capacity is stunting development of new products w Jason Webber

SecureVision

S2 E4: Synthetic biology’s potential to change the world. How the shortfall of semi-commercial fermentation capacity is stunting development of new products w Jason Webber